All Stories

  1. Platelet Levels of Brain-Derived Neurotrophic Factor in Adults with Autism Spectrum Disorder: Is There a Specific Association with Autism Spectrum Psychopathology?
  2. Oxalic Acid Treatment: Short-Term Effects on Enzyme Activities, Vitellogenin Content, and Residual Oxalic Acid Content in House Bees, Apis mellifera L.
  3. Plasma and Platelet Brain-Derived Neurotrophic Factor (BDNF) Levels in Bipolar Disorder Patients with Post-Traumatic Stress Disorder (PTSD) or in a Major Depressive Episode Compared to Healthy Controls
  4. Circulating Levels of 5-HT and BDNF in Adults with Autism Spectrum Conditions: An Investigation in a Sample of Subjects with Autism Spectrum Disorder, their First-degree Relatives and Controls
  5. Effects of Virgin Coconut Oil-Enriched Diet on Immune and Antioxidant Enzymatic Activity, Fat and Vitellogenin Contents in Newly Emerged and Forager Bees (Apis mellifera L.) Reared in Cages
  6. Variation of Circulating Brain-Derived Neurotrophic Factor (BDNF) in Depression: Relationships with Inflammatory Indices, Metabolic Status and Patients’ Clinical Features
  7. Unlocking the Secrets: Exploring the Biochemical Correlates of Suicidal Thoughts and Behaviors in Adults with Autism Spectrum Conditions
  8. Metabolic and Inflammatory Response in Post-Traumatic Stress Disorder (PTSD): A Systematic Review on Peripheral Neuroimmune Biomarkers
  9. Queen Caging and Oxalic Acid Treatment: Combined Effect on Vitellogenin Content and Enzyme Activities in the First Post-Treatment Workers and Drones, Apis mellifera L.
  10. Impact of Different Storage Temperature on the Enzymatic Activity of Apis mellifera Royal Jelly
  11. Effects of Two Commercial Protein Diets on the Health of Two Imago Ages of Apis mellifera L. Reared in Laboratory
  12. Effects of chestnut hydrolysable tannin enrichment in the artificial diet of forager bees, Apis mellifera
  13. Effect of Honey and Syrup Diets Enriched with 1,3-1,6 β-Glucans on Honeybee Survival Rate and Phenoloxidase Activity (Apis mellifera L. 1758)
  14. Neuroendocrine Response to Psychosocial Stressors, Inflammation Mediators and Brain-Periphery Pathways of Adaptation
  15. Focus on Human Monoamine Transporter Selectivity. New Human DAT and NET Models, Experimental Validation, and SERT Affinity Exploration
  16. The complex interactions among serotonin, insulin, leptin, and glycolipid metabolic parameters in human obesity
  17. Microbiota, Immune System and Autism Spectrum Disorders: An Integrative Model towards Novel Treatment Options
  18. Alpha-Synuclein FRET Biosensors Reveal Early Alpha-Synuclein Aggregation in the Endoplasmic Reticulum
  19. Antioxidant enzymes activity during age polyethism in Apis mellifera L., 1758
  20. Plasma redox and inflammatory patterns during major depressive episodes: a cross-sectional investigation in elderly patients with mood disorders
  21. Hydroxyindole-O-methyltransferase (HIOMT) activity in the retina of melatonin-proficient mice
  22. Psychopharmacology and ethnicity: A comparative study on Senegalese and Italian men
  23. Potential Diagnostic Value of Red Blood Cells α-Synuclein Heteroaggregates in Alzheimer’s Disease
  24. Social Cognition and Oxytocin in Huntington’s Disease: New Insights
  25. Effect of Valproate and Antidepressant Drugs on Clozapine Metabolism in Patients With Psychotic Mood Disorders
  26. Brain-Derived Neurotrophic Factor (BDNF) and Serotonin Transporter (SERT) in Platelets of Patients with Mild Huntington’s Disease: Relationships with Social Cognition Symptoms
  27. Emotions and the Body
  28. 137Caesium in samples of wild-grown Boletus edulis Bull. from Lucca province (Tuscany, Italy) and other Italian and European geographical areas
  29. Melatonin and pro-hypnotic effectiveness of the antidepressant Trazodone: A preliminary evaluation in insomniac mood-disorder patients
  30. Design, Synthesis, and Biological Evaluation of Imidazo[1,5-a]quinoline as Highly Potent Ligands of Central Benzodiazepine Receptors
  31. Tryptophan Biochemistry: Structural, Nutritional, Metabolic, and Medical Aspects in Humans
  32. Parkinson’s Disease and Alpha-Synucleinopathies: from Arising Pathways to Therapeutic Challenge
  33. Meet Our Editorial Board Member:
  34. Sulfur Metabolism and Sulfur-Containing Amino Acids: I- Molecular Effectors
  35. Sulfur Metabolism and Sulfur-Containing Amino Acids Derivatives – II: Autism Spectrum Disorders, Schizophrenia and Fibromyalgia
  36. Clozapine effects on adenylyl cyclase activity and serotonin type 1A receptors in human brain post-mortem
  37. The expression of platelet serotonin transporter (SERT) in human obesity
  38. Serotonin receptor of type 6 (5-HT6) in human prefrontal cortex and hippocampus post-mortem: An immunohistochemical and immunofluorescence study
  39. A link between oxytocin and serotonin in humans: Supporting evidence from peripheral markers
  40. The trace element content of top-soil and wild edible mushroom samples collected in Tuscany, Italy
  41. Distribution of Serotonin Receptor of Type 6 (5-HT6) in Human Brain Post-mortem. A Pharmacology, Autoradiography and Immunohistochemistry Study
  42. Synthesis of sulfonamide-containing N-hydroxyindole-2-carboxylates as inhibitors of human lactate dehydrogenase-isoform 5
  43. N-Hydroxyindole-based inhibitors of lactate dehydrogenase against cancer cell proliferation
  44. New Insight into the Central Benzodiazepine Receptor–Ligand Interactions: Design, Synthesis, Biological Evaluation, and Molecular Modeling of 3-Substituted 6-Phenyl-4 H -imidazo[1,5- a ][1,4]benzodiazepines and Related Compounds
  45. Discovery of N -Hydroxyindole-Based Inhibitors of Human Lactate Dehydrogenase Isoform A (LDH-A) as Starvation Agents against Cancer Cells
  46. Triazole-substituted N-hydroxyindol-2-carboxylates as inhibitors of isoform 5 of human lactate dehydrogenase (hLDH5)
  47. Serotonin transporter (SERT) and translocator protein (TSPO) expression in the obese ob/ob mouse
  48. Rosiglitazone reverses salbutamol-induced β2-adrenoceptor tolerance in airway smooth muscle
  49. Male axillary extracts modify the affinity of the platelet serotonin transporter and impulsiveness in women
  50. Modified RP-LC of Phenylthiocarbamyl Amino Acid Adducts in Plasma Acetonitrile Extracts Using Multiple Internal Standards and Photo-Diode UV Detection
  51. Alterations of the dopamine transporter in resting lymphocytes of patients with different psychotic disorders
  52. Human Serotonin Transporter Expression During Megakaryocytic Differentiation of MEG-01 Cells
  53. [3H]-YM-09151-2 binding sites in human brain postmortem
  54. Altered amino acid homeostasis in subjects affected by fibromyalgia
  55. ATP, calcium and magnesium levels in platelets of patients with primary fibromyalgia
  56. Synthesis and biological affinity of new imidazo- and indol-arylpiperazine derivatives: Further validation of a pharmacophore model for α1-adrenoceptor antagonists
  57. Ethyl 8-Fluoro-6-(3-nitrophenyl)-4 H -imidazo[1,5- a ][1,4]benzodiazepine-3-carboxylate as Novel, Highly Potent, and Safe Antianxiety Agent
  58. Neuropeptide Y in the Brain and Retina of the Adult Teleost Gilthead Seabream (Sparus aurata L.)
  59. Short-term effects of 3,4-methylen-dioxy-metamphetamine (MDMA) on 5-HT1A receptors in the rat hippocampus
  60. 1-Aminocyclopentane-1,2,4-tricarboxylic acids screening on glutamatergic and serotonergic systems
  61. Presence and Characterization of the Dopamine Transporter in Human Resting Lymphocytes
  62. Species Comparison of Adenosine Receptor Subtypes in Brain and Testis
  63. [3H] muscimol receptors sites in the carp (Cyprinus carpio L.) brain: Binding assay and autoradiographic distribution
  64. 3-[(aryl)(4-fluorobenzyloxy)methyl]piperidine derivatives: high-affinity ligands for the serotonin transporter
  65. Tubby protein in human lymphocytes from normal weight and obese subjects
  66. Synthesis and 5-HT2A, 5-HT1Aand α1-Binding Affinities of 2-[2-Hydroxy-3-(pyridin-3-yl-methyl)amino]-, 2-[2-Hydroxy-3-(2-pyridin-2-yl-ethyl)amino]- and 2-[2-Hydroxy-3-(4-N-methyl-piperazin-1-yl)-amino]propoxybenzaldehyde-O-(substituted) Benzyl Oximes
  67. Peripheral benzodiazepine receptors on platelets of fibromyalgic patients
  68. New 4-(4-methyl-phenyl)phthalazin-1(2H)-one derivatives and their effects on α1-receptors
  69. Synthesis of new piperazine–pyridazinone derivatives and their binding affinity toward α1-, α2-adrenergic and 5-HT1A serotoninergic receptors
  70. Binding of 3H-WIN-35,428 and 125I-RTI-121 to Human Platelet Membranes
  71. Synthesis of Stable Analogues of Geranylgeranyl Diphosphate Possessing a (Z,E,E)-Geranylgeranyl Side Chain, Docking Analysis, and Biological Assays for Prenyl Protein Transferase Inhibition
  72. Autoradiographic localization and binding study of benzodiazepines receptor sites in carp brain (Cyprinus carpio L.)
  73. Common Alterations in the Serotonin Transporter in Platelets and Lymphocytes of Psychotic Patients
  74. 1,8-Naphthyridin-4-one derivatives as new ligands of A2A adenosine receptors
  75. Variously Substituted (Phosphonoacetamido)Oxy Analogues of Geranylgeranyl Diphosphate (GGdP) as GGdP-transferase (GGTase) Inhibitors and Antiproliferative Agents
  76. Decreased elastase activity in circulating granulocytes of systemic sclerosis patients: a possible pathogenetic role
  77. Stable propylphosphonic acid analogues of geranylgeranyl diphosphate possessing inhibitory activity on geranylgeranyl protein transferase
  78. Phosphonomethylphosphorylmethyl(oxy)-analogues of geranylgeranyl diphosphate as stable and selective geranylgeranyl protein transferase inhibitors
  79. Immunohistochemical distribution of neuropeptide Y in the mesencephalon and rhombencephalon of carp, Cyprinus carpio L. (Cyprinidae: Teleostei)
  80. Study on Affinity Profile toward Native Human and Bovine Adenosine Receptors of a Series of 1,8-Naphthyridine Derivatives
  81. Design, synthesis, and α1-adrenoceptor binding properties of new arylpiperazine derivatives bearing a flavone nucleus as the terminal heterocyclic molecular portion
  82. In vitro effects of lead ions on peripheral benzodiazepine receptors and adenylyl cyclase activity in the mantle of Mytilus galloprovincialis
  83. [3H]PK11195 binding sites in human neutrophils: effect of fMLP stimulation and modulation in rheumatic diseases
  84. Absence of NK1 Receptors in Human Blood Lymphocytes and Granulocytes
  85. Synthesis of aniline-type analogues of farnesyl diphosphate and their biological assays for prenyl protein transferase inhibitory activity
  86. Stable analogues of geranylgeranyl diphosphate possessing improved geranylgeranyl versus farnesyl protein transferase inhibitory selectivity
  87. Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron
  88. α 1 -Adrenoceptor Antagonists. 6. 1 Structural Optimization of Pyridazinone−Arylpiperazines. Study of the Influence on Affinity and Selectivity of Cyclic Substituents at the Pyridazinone Ring and Alkoxy Groups at the Arylpiperazine Moiety
  89. [3H]-ketanserin binding sites in different psychiatric disorders
  90. Autoradiographic distribution of neuropeptide Y binding sites in the brain of the carp Cyprinus carpio L. (Cyprinidae, Teleostei)
  91. Peripheral-type benzodiazepine receptors in human mononuclear cells of patients affected by osteoarthritis, rheumatoid arthritis or psoriasic arthritis
  92. α1-Adrenoceptor antagonists. 5. Pyridazinone-arylpiperazines. Probing the influence on affinity and selectivity of both ortho-Alkoxy groups at the arylpiperazine moiety and cyclic substituents at the pyridazinone nucleus
  93. Studies of peripheral benzodiazepine receptors in mussels: comparison between a polluted and a nonpolluted site
  94. α 1 -Adrenoceptor Antagonists. 4. 1 Pharmacophore-Based Design, Synthesis, and Biological Evaluation of New Imidazo-, Benzimidazo-, and Indoloarylpiperazine Derivatives
  95. New 1,2,3-triazolo[1,5-a]quinoxalines: synthesis and binding to benzodiazepine and adenosine receptors. II
  96. Synthesis and biological activity of new 1,4-benzodioxan-arylpiperazine derivatives. Further validation of a pharmacophore model for α1-adrenoceptor antagonists
  97. α1-Adrenoceptor antagonists. rational design, synthesis and biological evaluation of new trazodone-like compounds
  98. Synthesis, Biological Evaluation, and Pharmacophore Generation of New Pyridazinone Derivatives with Affinity toward α 1 - and α 2 -Adrenoceptors 1
  99. Structure–activity relationships in a series of 8-substituted xanthines as A1-adenosine receptor antagonists
  100. Correlation between Platelet α2-Adrenoreceptors and Symptom Severity in Major Depression
  101. Peripheral-type benzodiazepine receptors in human blood cells of patients affected by migraine without aura
  102. A Novel Class of Highly Potent and Selective A 1 Adenosine Antagonists:  Structure−Affinity Profile of a Series of 1,8-Naphthyridine Derivatives
  103. Autoradiographic distribution of peripheral benzodiazepine receptors in the retina of the albino rabbit, Lepus cunicula
  104. New amino derivatives of 1,2,3-triazolo[4,5-d]pyrimidines and their affinity towards A1 and A2A adenosine receptors
  105. 1,2,3-Triazolo[4,5-d]pyridazines
  106. Synthesis of new pyridazinone derivatives and their affinity towards α1–α2-adrenoceptors
  107. Characterization of sulfonylurea receptors in isolated human pancreatic islets
  108. Influence of chemical pollution on brain adenosine receptors of Mugil cephalus
  109. Adenosine receptors: synthesis, structure-activity relationships and biological activity of new 6-amino purine derivatives
  110. 1,2,3-Triazolo[1,5-a]quinoxalines: synthesis and binding to benzodiazepine and adenosine receptors
  111. Novel 3-Aralkyl-7-(amino-substituted)-1,2,3-triazolo[4,5- d ]pyrimidines with High Affinity toward A 1 Adenosine Receptors
  112. Binding of the benzodiazepine ligand [3H]-Ro 15–1788 to brain membrane of the saltwater fish Mullus surmuletus
  113. The serotonin transporter from human brain: Purification and partial characterization
  114. Characterization of adenosine receptors in Mullus surmuletus
  115. Purification and characterization of the serotonin transporter from human brain